Butalbital, Acetaminophen, and Caffeine Capsules

CHEBI:CHEBI_756040

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
BUTALBITAL
rxcui
889520
product_type
HUMAN PRESCRIPTION DRUG
route
ORAL
marketing_category
ANDA
listing_expiration_date
20241231
active_ingredient_strength
300 mg/1
dosage_form
CAPSULE
unii
3G6A5W338E
marketing_start_date
20191217
package_marketing_start_date
20191217
brand_name
Butalbital, Acetaminophen, and Caffeine
brand_name_base
Butalbital, Acetaminophen, and Caffeine
nui
M0023046
pharm_class_epc
Methylxanthine [EPC]
pharm_class
Xanthines [CS]
pharm_class_pe
Central Nervous System Stimulation [PE]
pharm_class_cs
Xanthines [CS]
labeler_name
Lannett Company, Inc.
manufacturer_name
Lannett Company, Inc.
generic_name
Butalbital, Acetaminophen, and Caffeine Capsules
product_ndc
0527-4095
application_number
ANDA212082
spl_id
146b5639-6699-471c-ae28-1f576bbead9f
package_ndc
0527-4095-37
package_description
100 CAPSULE in 1 BOTTLE (0527-4095-37)
spl_set_id
4d62259d-a582-4621-b62e-3d5640cadf7c
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class